Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: A prospective randomized study
Karen L Fuller, Yi Yuen Wang, Mark J Cook, Michael A Murphy, Wendyl J D'Souza
Epilepsia | WILEY | Published : 2013
Karen Fuller has received an unrelated travel grant from UCB Pharma. Mark Cook has received travel grants and educational honoraria from UCB Pharma, educational honoraria from Sanofi Australia, and travel grants from SciGen Pharmaceuticals. Wendyl D'Souza has received travel, investigator-initiated, and speaker honoraria from UCB Pharma, educational grants from Novartis Pharmaceuticals and Pfizer Pharmaceuticals, educational, travel and fellowship grants from GSK Neurology Australia, and honoraria from SciGen Pharmaceuticals. Yi Yuen Wang and Michael Murphy report no conflicts of interest. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.